Atara Biotherapeutics Investor Relations Material

Atara Biotherapeutics Inc. is a biotechnology company focused on developing therapies for cancer, autoimmune, and viral diseases. The company specializes in allogeneic T-cell immunotherapy, using off-the-shelf T-cells to target and treat diseases. Atara's lead programs are centered around developing treatments for conditions such as Epstein-Barr virus-associated cancers and multiple sclerosis. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.